Willow Biosciences (TSE:WLLW) Hits New 12-Month Low – Should You Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report) shares hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.02 and last traded at C$0.02, with a volume of 784320 shares traded. The stock had previously closed at C$0.03.

Willow Biosciences Price Performance

The company has a quick ratio of 19.71, a current ratio of 0.70 and a debt-to-equity ratio of 131.61. The stock has a market cap of C$3.61 million, a P/E ratio of -0.42 and a beta of 1.13. The firm has a 50 day moving average price of C$0.06 and a 200 day moving average price of C$0.08.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Featured Articles

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.